Clinical TrialID 1322

A Study of Baked Milk Tolerance to Treat Eosinophilic Esophagtis

NCT05606705

Eosinophilic Esophagitis

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
1322
Evidence Id
1322
Core Evidence Id
1322
Source Clinical Trial Id
1304
Herb2 Clinical Trial Id
HBCT001304
Nct Id
NCT05606705
Title
A Study of Baked Milk Tolerance to Treat Eosinophilic Esophagtis
Status
Enrolling_By_Invitation
Phase
Study Result
No
Study Condition
Eosinophilic Esophagitis
Study Type
Interventional
Study Design
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DIETARY_SUPPLEMENT: Baked Milk
Intervention Allocation
Intervention Model
Single_Group
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
26
Outcome Measure
Histological remission, Number of patients in histologic remission at the end of a 6 week trial of baked milk. Histologic remission is defined by \<15 eos per HPF on cytosponge., 6 weeks
Sponsor Collaborator
Mayo Clinic
Funded By
OTHER
Location
Mayo Clinic Minnesota, Rochester, Minnesota, 55905, United States
Other Id
22-007941
Start Date
2022-12-05
Primary Completion Date
2024-12
Completion Date
2024-12
First Posted
2022-11-07
Results First Posted
Last Update Posted
2023-11-28
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05606705
Title Cn
Title En
A Study of Baked Milk Tolerance to Treat Eosinophilic Esophagtis
Bilingual Status
semi_complete